Report Company Directory

Profound Medical Corp

• PRO FAMILIA and Profound Medical Celebrate 500 Sonalleve® Procedures, Expanding Access to Incision-Free Care for Women’s Health by GlobeNewsWire
• Profound Medical Announces Upcoming Investor Events by GlobeNewsWire
• Mount Sinai Becomes First in Metro New York to Deliver Incision-Free, MRI-Guided Prostate Treatment with TULSA-PRO® by GlobeNewsWire
• Profound Surpasses 2025 TULSA-PRO® Installed Base Goal by GlobeNewsWire
• Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case by GlobeNewsWire
• Profound Medical Corp. Announces Closing of Private Placement by GlobeNewsWire
• Profound Medical Corp: 1 director by SmartInsider
• Profound Medical Corp. Announces Upsize of Private Placement by GlobeNewsWire
• Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th by GlobeNewsWire
• Profound Medical Corp. Announces Pricing of up to $40 Million Financing Comprised of a $36 Million Registered Direct Offering and a Subsequent $4 Million Private Placement by GlobeNewsWire

PROFRAC HLDG CORP

• European Morning Research Summary by Stifel
• InsiderInsights Weekly Report: September 13, 2025 by InsiderInsights.com
• InsiderInsights Weekly Report: September 9, 2025 by InsiderInsights.com
• InsiderInsights Weekly Report: August 23, 2025 by InsiderInsights.com
• InsiderInsights.com Daily Ratings Report: August 18, 2025 by InsiderInsights.com
• InsiderInsights Weekly Report: May 17, 2025 by InsiderInsights.com
• InsiderInsights.com Daily Ratings Report: May 16, 2025 by InsiderInsights.com
• InsiderInsights.com Daily Ratings Report: May 14, 2025 by InsiderInsights.com
• InsiderInsights.com Daily Ratings Report: May 13, 2025 by InsiderInsights.com
• InsiderInsights Weekly Report: March 1, 2025 by InsiderInsights.com

PROFUSA INC.

• Profusa Announces 1-for-75 Reverse Stock Split by GlobeNewsWire
• Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026 by GlobeNewsWire
• Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue by GlobeNewsWire
• Profusa Adds Leading Greek Vascular Surgeon to Customer Base by GlobeNewsWire
• Profusa Bolsters European Commercial Network with New French Distributor, MedSell by GlobeNewsWire
• Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35 by GlobeNewsWire
• Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025 by GlobeNewsWire
• Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026 by GlobeNewsWire
• Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025 by GlobeNewsWire
• Profusa Announces Third Quarter Business and Financial Highlights by GlobeNewsWire

PROFUTURO AFP

PROG Holdings Inc.

• Aarons Company Inc (The): 1 director by SmartInsider
• Monthly LMI Update Independent Investment Research by Independent Investment Research
• Raymond James Afternoon Notes - CUB, ZIOP by Raymond James
• AAN | Takeaways Sell-Side Conference Call – Progressive & Aarons Businesses by Raymond James
• Raymond James Afternoon Notes - OCUL by Raymond James
• RCII | Outlook Remains Favorable; Takeaways From Investor Meetings by Raymond James
• Raymond James Morning Notes - AAPL, APTV, ATNI, BC, CBRE, CDNA, EXP, FB, FIS, GOOG, GPN, HBNC, MPWR, OSK, RWT, SAIA, SCI, TFX, UVSP, WCN by Raymond James
• AAN | Trends Remain Strong - Reaffirm Strong Buy & $68 Target by Raymond James
• Aaron's (AAN US) - Aaron's tops expectations in Q3; maintain Buy by Berenberg
• Portfolio Strategy | Morning Brew: October 29, 2020 by Raymond James